# 2026-09438: FDA's Yearly Germ Testing Guidelines Get Refreshed

2026-09438, 21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria web page, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-05-12, effective 2026-05-12 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-09438
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-09438
- Title: 21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria web page
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 25894
- Published: 2026-05-12
- Effective: 2026-05-12
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA's Yearly Germ Testing Guidelines Get Refreshed

## Summary

The FDA just dropped its yearly update on how it tests germs to see which medicines work best. This affects doctors, labs, and drug makers who rely on these test rules to fight infections smarter and faster. The updates keep everyone on the same page and help save time and money by improving treatment choices—comments on these changes are open now!

## Abstract

The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of the Agency's annual compilation of notices of updates to the Agency's Susceptibility Test Interpretive Criteria web page. The Agency established the Susceptibility Test Interpretive Criteria web page on December 13, 2017, and since establishment has provided updates to both the format of the web pages and the susceptibility test interpretive criteria identified and recognized by FDA on the web pages. FDA is publishing this notice in accordance with procedures established by the 21st Century Cures Act (Cures Act).

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-09438 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/12/2026-09438/21st-century-cures-act-annual-compilation-of-notices-of-updates-from-the-susceptibility-test)
- [2026-09438 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-12/pdf/2026-09438.pdf)

## Related
- [Previous: 2026-09437, Agency Information Collection Activities; Submission for OMB Review; Comment Re…](https://policyrisk.com/federal-register/2026-09437)
- [Next: 2026-09439, Certain Ink Cartridges and Components Thereof II; Notice of a Commission Determ…](https://policyrisk.com/federal-register/2026-09439)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-09438 (as of 2026-06-08).
